Are there specific characteristics of a preferred partner among big pharma, given the technologies that you have?
Mr. Levin: For a drug delivery company, the preferred partner is one that has proven sales and marketing capabilities – a company with a presence in the therapeutic area you are looking to sell your technology into. Optimally, we’d like to partner with a company that has proven itself to be capable of generating large revenues, so our efforts on their behalf will be rewarded with a royalty stream that has impact. The drug delivery company may be bringing novel technology and some development experience, but if the potential partner cannot bring commercial expertise, then a critical part of the equation is missing. DDT: From the pharma company perspective, who should drug delivery companies initially be talking to within your organization? Mr. Trivedi: I suggest a two-prong approach. The traditional approach is when a drug delivery company approaches the business development group. Although it is important to contact our business development group, there is often not sufficient scientif
